Woodline Partners »

Regeneron Pharmaceuticals shares owned by Woodline Partners

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Woodline Partners from 13F filings

Historical chart of Woodline Partners investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by Woodline Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by Woodline Partners

Quarter filed Position value Share count Share price at filing
2023-09-30 $112M 137k 822.96
2023-06-30 $34M 48k 718.54
2023-03-31 $127M 154k 821.67
2022-12-31 $115M 160k 721.49
2022-09-30 $129M 187k 688.87
2022-06-30 $31M 53k 591.13
2022-03-31 $74M 106k 698.42
2021-12-31 $57M 90k 631.52
2021-09-30 $46M 76k 605.17
2021-06-30 $44M 78k 558.54
2021-03-31 $88M 186k 473.14
2020-12-31 $9.8M 20k 483.12
2020-06-30 $19M 31k 623.66
2020-03-31 $13M 28k 488.30